Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Dreamy Jet Study
NCT06919198Phase 1Withdrawn
- Sponsor
- University of Wisconsin–Madison
- Start
- Sep 2025
- Primary completion
- Aug 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ketamine in Procedural anxiety, sponsored by University of Wisconsin–Madison. Primary endpoint: Feasibility of procedural success at 3 hours. Planned start Sep 2025; status: withdrawn.
02
Drugs
ketamine
03
Conditions
Procedural anxiety
Beyond the preview
Go deeper on NCT06919198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06919198.